Simple Summary Non-alcoholic fatty liver disease (NAFLD) is a widespread disease
associated with metabolic disorders, such as obesity. In recent years, there has been …

The rate at which obesity is becoming an epidemic in many countries is alarming. Obese
individuals have a high risk of developing elevated intraocular pressure and glaucoma …

In the present study, we characterized the distinctive signatures of the gut microbiota (GM)
from overweight/obese patients (OB), and normal-weight controls (NW), both of Sardinian …

Vitamin D deficiency affects approximately 80% of individuals in some countries and has
been linked with gut dysbiosis and inflammation. While the benefits of vitamin D …

Background Leptin-deficient ob/ob mice and leptin receptor-deficient db/db mice are
commonly used mice models mimicking the conditions of obesity and type 2 diabetes …

Diabetes mellitus (DM) burden encompasses diabetic kidney disease (DKD), the leading
cause of end-stage renal disease worldwide. Despite compelling evidence indicating that …

Mice are widely used as experimental models for gut microbiome (GM) studies, yet the
majority of mouse GM members remain uncharacterized. Here, we report the construction of …

Finishing weight is a key economic trait in the domestic pig industry. Evidence has linked the
gut microbiota and SCFAs to health and production performance in pigs. Nevertheless, for …

Introduction The human gut microbiota (GM) is a dynamic system which ecological
interactions among the community members affect the host metabolism. Understanding the …

Microorganisms including bacteria, viruses, protozoa, and fungi living in the gastrointestinal
tract are collectively known as the gut microbiota. Dysbiosis is the imbalance in microbial …